Zimmer Biomet Boosts FY23 Outlook - Update
(RTTNews) - While reporting financial results for the first quarter on Tuesday, musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) raised its adjusted earnings and revenue growth outlook for the full-year 2023.
For fiscal 2023, the company now projects adjusted earnings in a range of $7.40 to $7.50 per share on revenue growth of 5 to 6 percent from last year on a reported basis.
Previously, the company expected adjusted earnings in a range of $6.95 to $7.15 per share on projected revenue growth of 1.5 to 3.5 percent from last year on a reported basis.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $7.06 per share on revenue growth of 3.0 percent to $7.14 billion for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Zimmer Biomet Trims FY24 Revenue Growth Outlook; To Acquire OrthoGrid Systems - Update
Zimmer Biomet Receives FDA's 510(k) Clearance For ROSA Shoulder System
Zimmer Biomet Guides FY24 Above Estimates - Update
Zimmer Biomet Trims FY23 Revenue Growth Outlook - Update
Zimmer Biomet Promotes COO Ivan Tornos To Succeed Bryan Hanson As President And CEO
Zimmer Biomet Receives FDA 510(k) Clearance For Identity Shoulder System
U.S. Pending Home Sales Fall More Than Expected In July
